[The results of a clinical trial of the new drug agent carbabenzpyride].
Analyzed were results of a clinical use of a new drug carbabanzpyrid in 57 patients as an analgetic, antipyretic, anti-inflammatory, interferonogenic drug. The drug proved effective in the complex treatment of several diseases, accompanied by fever, pain syndromes of different genesis and location, acute respiratory viral infections, active inflammatory processes of different etiology including bronchitis, pneumonia, active rheumatism, arthralgias, myalgias. The drug was of little efficacy in infections-allergic polyarthritis with a marked exudative component.